Mic-1


Also found in: Wikipedia.

Mic-1

Microprogramming language, used in Andrew Tanenbaum's book.

See Mac-1.

[Structured Computer Organization, A.S. Tanenbaum, 3rd ed, P-H 1989, Sect 4.4, 4.5].
References in periodicals archive ?
This study showed that the overall mean serum MIC-1 level of patients with early-stage NSCLC was 1325 [+ or -] 848 pg/ml, which was significantly higher than those of BPD patients (848 [+ or -] 183 pg/ml; t = 7.
Multivariate logistic regression analyses on variables including age, gender, and serum MIC-1 showed that MIC-1 was a potential diagnostic biomarker for NSCLC ( P < 0.
In early-stage NSCLC patients, serum levels of MIC-1 were correlated with age ( P = 0.
Serum levels of MIC-1 were significantly increased in women ( P = 0.
Of those patients who died during the follow-up period, serum MIC-1 levels before treatment (1859 [+ or -] 737 pg/ml) were considerably greater than those of the survived patients (1428 [+ or -] 852 pg/ml; P = 0.
Patients were grouped using a serum MIC-1 level of 1465 pg/ml as a criterion [Table 2].
Kaplan-Meier survival curve showed that the 3-year survival rate of patients with serum MIC-1 ≥1465 pg/ml was 77.
Univariate Cox survival analysis indicated that the high mortality risk was significantly associated with high serum levels of MIC-1 ( HR : 4.
In this study, a double antibody sandwich serum ELISA serum MIC-1 test kit was used to conduct a serologic study on early-stage NSCLC patients, BPD patients, and healthy controls.
sup][21],[22] Therefore, it is possible that a specific serum marker, such as MIC-1, may assist LDCT in improving early detection rates of NSCLC.
By targeting MIC-1, protein levels dropped 300 to 400 percent in animal and human tissue samples, preventing blood vessel formation and decreasing tumor development by about 300 percent.
Therapies removing MIC-1 from the blood of patients could be used to prevent tumor vessel development and as a result, the tumors would not be able to get bigger because of a lack of needed nutrition and removal of toxic cell waste products.